|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA07100007
|
methyl-2R-hydroxy-goshuyic acid
|
methyl 2R-hydroxy-5Z,8Z-tetradecadienoate
|
SFE 15:2;O
|
C15H26O3
|
254.188195
|
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010075
|
PGF2alpha-EA
|
N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:3;O3
|
C22H39NO5
|
397.282824
|
|
LMFA03010152
|
PGD2-EA
|
N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
|
LMFA07070125
|
2E,9Z-Octadecadienoylcarnitine
|
3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:2
|
C25H45NO4
|
423.334859
|
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
|
LMFA07070127
|
2E,7Z-Hexadecadienoylcarnitine
|
3-[(2E,7Z)-hexadeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070128
|
(7Z)-3S-hydroxyhexadecenoylcarnitine
|
3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:1;O
|
C23H43NO5
|
413.314124
|
|
LMFA07070129
|
(5Z)-3S-hydroxytetradecenoylcarnitine
|
3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070130
|
2E,5Z-tetradecadienoylcarnitine
|
3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070134
|
2E,decenoylcarnitine
|
3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
|
LMFA07070133
|
3S-hydroxyoctanoylcarnitine
|
3S-{[-3-hydroxyoctanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 8:0;O
|
C15H29NO5
|
303.204574
|
|
LMFA07070132
|
3S-hydroxydecanoylcarnitine
|
3S-{[-3-hydroxydecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 10:0;O
|
C17H33NO5
|
331.235874
|
|
LMFA07070131
|
3S-hydroxyhexadecanoylcarnitine
|
3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:0;O
|
C23H45NO5
|
415.329774
|
|
LMFA02000412
|
13S-HOME(9Z)
|
13S-hydroxy-9Z-octadecenoic acid
|
FA 18:1;O
|
C18H34O3
|
298.250795
|
|
LMFA02000413
|
10,13-Dihydroxystearic acid
|
10,13-Dihydroxyoctadecanoic acid
|
FA 18:0;O2
|
C18H36O4
|
316.261360
|
|
LMFA03050032
|
11,12,15-THETA
|
11,12,15-trihydroxy-5Z,8Z,13E-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240625
|
|
LMFA01060242
|
15Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,15Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4
|
394.308310
|
|
LMFA01060243
|
16Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,16Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4
|
394.308310
|
|
LMFA01060244
|
17Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4
|
394.308310
|
|
LMFA01060251
|
15Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,15Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|
|
LMFA01060252
|
16Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,16Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|
|
LMFA01060253
|
17Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|
|
LMFA01060254
|
19Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,19Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|
|
LMFA01060255
|
18Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,18Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|
|
LMFA01060256
|
21Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,21Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|
|
LMFA03010053
|
PGE1 alcohol
|
1,11R,15S-trihydroxy-13E-prosten-9-one
|
FA 20:2;O2
|
C20H36O4
|
340.261360
|
|
LMFA08040075
|
9-hydroxy-linoleoyl-EA
|
N-(9S-hydroxy-10E,12Z-octadecadienoyl)-ethanolamine
|
NAE 18:2;O
|
C20H37NO3
|
339.277344
|
|
LMFA08040074
|
13-hydroxy-linoleoyl-EA
|
N-(13S-hydroxy-9Z,11E-octadecadienoyl)-ethanolamine
|
NAE 18:2;O
|
C20H37NO3
|
339.277344
|
|
LMFA03060121
|
Okeanic acid A
|
11S,14R,15S-trihydroxyeicosa-5Z,8Z,12E,17Z-tetraenoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224975
|
|
LMFA04000093
|
Resolvin T3
|
7,12,13-Trihydroxy-8Z,10E,14E,16Z,19Z-docosapentaenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240625
|
|
LMFA01060225
|
Porrigenic acid
|
(S)-(10E,12E)-14- hydroxy-9-oxo-10,12-octadecadienoic acid
|
FA 18:3;O2
|
C18H30O4
|
310.214410
|
|
LMFA01020450
|
Hemibourgeanic acid
|
3S-hydroxy-2S,4R,6R-trimethyloctanoic acid
|
FA 11:0;O
|
C11H22O3
|
202.156895
|
|
LMFA03010131
|
PGB1
|
9-oxo-15S-hydroxy-8(12),13E-prostadienoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230060
|
|
LMFA02000414
|
Govanic Acid
|
7,8,9-trihydroxy-10Z-octadecenoic acid
|
FA 18:1;O3
|
C18H34O5
|
330.240625
|
|
LMFA03010217
|
15S-hydroperoxy-PGE2
|
9-oxo-11R-hydroxy-15S-hydroperoxy-5Z,13E-prostadienoic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219890
|